Related Experiment Videos
Modified haemoglobins as oxygen-transporting blood substitutes
1Academic Unit of Anaesthesia, General Infirmary at Leeds.
British Journal of Hospital Medicine
|April 3, 1996
Summary
Modified hemoglobin solutions, developed from various sources, serve as red blood cell substitutes. These solutions offer oxygen transport and exhibit beneficial effects on blood flow and blood pressure.
Area of Science:
- Biomedical Engineering
- Hematology
- Pharmacology
Background:
- Hemoglobin solutions are being developed as potential red blood cell substitutes.
- Sources include outdated human blood, bovine, and recombinant hemoglobins.
- Modifications aim to improve oxygen affinity, reduce oncotic activity, and extend intravascular half-life.
Purpose of the Study:
- To summarize the development and properties of modified hemoglobin solutions.
- To highlight their potential as red blood cell substitutes.
- To discuss their non-oxygen-carrying functions.
Main Methods:
- Review of existing literature on hemoglobin solution development.
- Analysis of modifications to hemoglobin properties (oxygen affinity, oncotic activity, half-life).
- Examination of observed physiological effects (vasopressor, blood flow improvement).
Main Results:
- Modified hemoglobin solutions demonstrate efficacy as oxygen carriers.
- Key modifications successfully reduced oxygen affinity and oncotic activity.
- Intravascular half-life was prolonged through various modification techniques.
- Additional properties include vasopressor effects and enhanced regional blood flow.
Conclusions:
- Modified hemoglobin solutions represent a promising alternative to traditional red blood cell transfusions.
- Their therapeutic potential extends beyond oxygen delivery to include circulatory support.
- Further research is warranted to fully elucidate their clinical applications and safety profile.